EMEA-001687-PIP01-14-M03

Key facts

Active substance
fostemsavir (tromethamine)
Therapeutic area
Infectious diseases
Decision number
P/0040/2019
PIP number
EMEA-001687-PIP01-14-M03
Pharmaceutical form(s)
Prolonged-release tablet
Condition(s) / indication(s)
Treatment of human immunodeficiency virus (HIV-1) infection
Route(s) of administration
Oral use
Contact for public enquiries
ViiV Healthcare UK Ltd

Tel.  +44 2083806303
E-mail: karen.m.grainger@viivhealthcare.com

Decision type
PM: decision on the application for modification of an agreed PIP

Decision

How useful was this page?

Add your rating